肝脏 ›› 2025, Vol. 30 ›› Issue (11): 1469-1474.

• 肝肿瘤 • 上一篇    下一篇

基因3型HCV相关肝细胞癌患者临床特征及生存分析

木唤, 张映媛, 牟春燕, 何愿强, 常丽仙, 刘春云, 刘立, 许丹青   

  1. 650041 昆明 昆明市第三人民医院云南省传染性疾病临床医学中心
  • 收稿日期:2025-02-12 出版日期:2025-11-30 发布日期:2026-02-09
  • 通讯作者: 刘立,Email:liuli197210@163.com;许丹青,Email:xudanqing2022@163.com
  • 基金资助:
    佑安专科联盟科研专项基金(LM202014);昆明市卫生科研项目基金(2025-03-08-002)

The clinical characteristics and survival analysis of patients with genotype 3 hepatitis C viral infection-related hepatocellular carcinoma

MU Huan, ZHANG Ying-yuan, MOU Chun-yan, HE Yuan-qiang, CHANG Li-xian, LIU Chun-yun, LIU Li, XU Dan-qing   

  1. Yunnan Provincial Clinical Medical Center for Infectious Diseases, the Third People′s Hospital of Kunming, Kunming 650041, China
  • Received:2025-02-12 Online:2025-11-30 Published:2026-02-09
  • Contact: LIU Li,Email:liuli197210@163.com;XU Dan-qing,Email:xudanqing2022@163.com

摘要: 目的 探讨基因3型HCV相关肝细胞癌(HCV-HCC)患者临床特征及生存分析。方法 收集 2020 年 1 月至 2022 年12月昆明市第三人民医院基因 3 型HCV-HCC患者 100 例。随访2年,将患者分为死亡组及存活组,收集相关临床资料、生化指标、个人史等。单因素和多因素 Cox 比例风险回归模型分析基因3型HCV-HCC患者死亡的影响因素。以受试者工作特征曲线下面积(AUC)评估各项目对死亡的预测效能。应用 Kaplan-Meier 法绘制凝血酶原时间(PT)、合并腹腔积液、合并出血及联合预测的生存曲线。结果 死亡组 45例,生存组55例。CNLC肿瘤分期 Ⅰ 期26例,Ⅱ 期28例,Ⅲ 期36例,Ⅳ 期 10 例;Child-Pugh 分级 A 级 33例,B 级 42 例,C 级 25 例。Cox 单因素及多因素分析结果显示:PT (HR=1.138, 95%CI: 1.020~1.270, P=0.020)、合并腹腔积液(HR=1.414, 95%CI: 1.016~1.970, P=0.040)、合并出血(HR=1.901, 95%CI: 1.337~2.704, P<0.001)是导致HCV-HCC患者死亡的独立影响因素。PT预测死亡的AUC=0.763,合并出血的AUC=0.797,合并腹腔积液AUC=0.653,3个指标联合预测的AUC=0.892。结论 基因 3 型HCV-HCC患者 PT、合并腹腔积液、合并出血均为影响生存的危险因素,可作为临床预测患者预后的指标。

关键词: 基因3型丙型肝炎病毒, 肝细胞癌, Cox 回归模型, Kaplan-Meier 分析

Abstract: Objective To investigate the clinical characteristics and survival analysis of patients with genotype 3 (GT3) hepatitis C viral infection related hepatocellular carcinoma (HCV-HCC). Methods One hundred patients with GT3 HCV-HCC in the Third People′s Hospital of Kunming from January 2020 to December 2022 were collected in this study. According to the patient′s admission time and their outcomes in 2-year follow-up, the patients were divided into a death group and a survival group. The relevant clinical data, biochemical indicators, personal history, and other related indicators of these patients were collected. Univariate and multivariate Cox proportional hazards regression models were used to analyze the influencing factors of mortality in these patients with GT3 HCV-HCC. Receiver operating characteristic curve (ROC curve) and area under the curve (AUC) analysis was adopted. Survival curves for liver cancer were drawn using Kaplan Meier method with prothrombin time (PT), complications of ascites and bleeding as predictive indicators. Results There were 45 cases (45%) in the death group, and 55 cases (55%) in the survival group. According to the CNLC tumor staging system in China, there were 26 cases in stage I, 28 cases in stage II, 36 cases in stage III, and 10 cases in stage IV. According to the Child-Pugh grading system, there were 32 cases in stage A, 46 cases in stage B, and 22 cases in stage C. The results of Cox univariate and multivariate analysis showed that prothrombin time (PT) (HR=1.138, 95%CI 1.020~1.270, P=0.020), complication of peritoneal effusion (HR=1.414, 95%CI 1.016~1.970, P=0.040), and complication of bleeding (HR=1.901, 95% CI 1.337~2.704, P<0.001) were independent factors leading to mortality in patients with HCV-HCC. According to the ROC curve analysis, the maximum value of PT (AUC=0.763), the maximum value of complication of bleeding (AUC=0.797), the maximum value of complicaion of ascites (AUC=0.653), and the combined prediction of the three indicators for the maximum value (AUC=0.892). Conclusion PT, complication of ascites, and complication of bleeding are all risk factors affecting the survival of patients with GT3 HCV-HCC, and may serve as clinical indicators for predicting their prognosis.

Key words: Genotype 3 hepatitis C virus, Hepatocellular carcinoma, Cox regression model, Kaplan-Meier analysis